Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells

Cheryl S. Watson, Dragoslava Zivadinovic, Yow Jiun Jeng, Rebecca A. Alyea, Terumi Midoro-Horiuti, Randall Goldblum, Anannya Banga

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Estrogens act via multiple membrane-associated receptors (α, β, and GPR30) to mediate diverse rapid signaling cascades affecting functional endpoints in both normal and cancer cells. The mitogen-activated protein kinases are a summative signaling node that integrates upstream signaling cascades into responses for major functional cellular outcomes such as proliferation, migration, differentiation, and death. These responses are complex; they oscillate with time, as well as fluctuate up and down with increasing ligand concentration (hormesis). Nonphysiologic estrogenic compounds also use these receptors and signaling systems, but do so imperfectly, causing disruptions to both the phasing and dose-responsiveness of physiologic estrogens. Disruptions to the signaling of different physiologic estrogens could cause life stage-specific tissue malfunctions or cancer vulnerabilities.

Original languageEnglish (US)
Title of host publicationAdvances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers
PublisherSpringer New York
Pages129-142
Number of pages14
ISBN (Print)9781461417644, 1461417635, 9781461417637
DOIs
StatePublished - Aug 1 2011
Externally publishedYes

Fingerprint

Endocrine Gland Neoplasms
Endocrine Cells
Estrogens
Hormesis
Mitogen-Activated Protein Kinases
Neoplasms
Ligands
Membranes

Keywords

  • Breast cancer
  • Estrogens
  • Immune system
  • Ligand mixtures
  • Membrane estrogen receptors
  • Neurons
  • Nongenomic
  • Nonmonotonic
  • Pituitary
  • Xenoestrogens

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Watson, C. S., Zivadinovic, D., Jeng, Y. J., Alyea, R. A., Midoro-Horiuti, T., Goldblum, R., & Banga, A. (2011). Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells. In Advances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers (pp. 129-142). Springer New York. https://doi.org/10.1007/978-1-4614-1764-4_8

Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells. / Watson, Cheryl S.; Zivadinovic, Dragoslava; Jeng, Yow Jiun; Alyea, Rebecca A.; Midoro-Horiuti, Terumi; Goldblum, Randall; Banga, Anannya.

Advances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers. Springer New York, 2011. p. 129-142.

Research output: Chapter in Book/Report/Conference proceedingChapter

Watson, CS, Zivadinovic, D, Jeng, YJ, Alyea, RA, Midoro-Horiuti, T, Goldblum, R & Banga, A 2011, Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells. in Advances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers. Springer New York, pp. 129-142. https://doi.org/10.1007/978-1-4614-1764-4_8
Watson CS, Zivadinovic D, Jeng YJ, Alyea RA, Midoro-Horiuti T, Goldblum R et al. Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells. In Advances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers. Springer New York. 2011. p. 129-142 https://doi.org/10.1007/978-1-4614-1764-4_8
Watson, Cheryl S. ; Zivadinovic, Dragoslava ; Jeng, Yow Jiun ; Alyea, Rebecca A. ; Midoro-Horiuti, Terumi ; Goldblum, Randall ; Banga, Anannya. / Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells. Advances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers. Springer New York, 2011. pp. 129-142
@inbook{0fe6e706f28645c29a598940fb37f0c0,
title = "Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells",
abstract = "Estrogens act via multiple membrane-associated receptors (α, β, and GPR30) to mediate diverse rapid signaling cascades affecting functional endpoints in both normal and cancer cells. The mitogen-activated protein kinases are a summative signaling node that integrates upstream signaling cascades into responses for major functional cellular outcomes such as proliferation, migration, differentiation, and death. These responses are complex; they oscillate with time, as well as fluctuate up and down with increasing ligand concentration (hormesis). Nonphysiologic estrogenic compounds also use these receptors and signaling systems, but do so imperfectly, causing disruptions to both the phasing and dose-responsiveness of physiologic estrogens. Disruptions to the signaling of different physiologic estrogens could cause life stage-specific tissue malfunctions or cancer vulnerabilities.",
keywords = "Breast cancer, Estrogens, Immune system, Ligand mixtures, Membrane estrogen receptors, Neurons, Nongenomic, Nonmonotonic, Pituitary, Xenoestrogens",
author = "Watson, {Cheryl S.} and Dragoslava Zivadinovic and Jeng, {Yow Jiun} and Alyea, {Rebecca A.} and Terumi Midoro-Horiuti and Randall Goldblum and Anannya Banga",
year = "2011",
month = "8",
day = "1",
doi = "10.1007/978-1-4614-1764-4_8",
language = "English (US)",
isbn = "9781461417644",
pages = "129--142",
booktitle = "Advances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers",
publisher = "Springer New York",

}

TY - CHAP

T1 - Nongenomic actions of estrogens and xenoestrogens affecting endocrine cancer cells

AU - Watson, Cheryl S.

AU - Zivadinovic, Dragoslava

AU - Jeng, Yow Jiun

AU - Alyea, Rebecca A.

AU - Midoro-Horiuti, Terumi

AU - Goldblum, Randall

AU - Banga, Anannya

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Estrogens act via multiple membrane-associated receptors (α, β, and GPR30) to mediate diverse rapid signaling cascades affecting functional endpoints in both normal and cancer cells. The mitogen-activated protein kinases are a summative signaling node that integrates upstream signaling cascades into responses for major functional cellular outcomes such as proliferation, migration, differentiation, and death. These responses are complex; they oscillate with time, as well as fluctuate up and down with increasing ligand concentration (hormesis). Nonphysiologic estrogenic compounds also use these receptors and signaling systems, but do so imperfectly, causing disruptions to both the phasing and dose-responsiveness of physiologic estrogens. Disruptions to the signaling of different physiologic estrogens could cause life stage-specific tissue malfunctions or cancer vulnerabilities.

AB - Estrogens act via multiple membrane-associated receptors (α, β, and GPR30) to mediate diverse rapid signaling cascades affecting functional endpoints in both normal and cancer cells. The mitogen-activated protein kinases are a summative signaling node that integrates upstream signaling cascades into responses for major functional cellular outcomes such as proliferation, migration, differentiation, and death. These responses are complex; they oscillate with time, as well as fluctuate up and down with increasing ligand concentration (hormesis). Nonphysiologic estrogenic compounds also use these receptors and signaling systems, but do so imperfectly, causing disruptions to both the phasing and dose-responsiveness of physiologic estrogens. Disruptions to the signaling of different physiologic estrogens could cause life stage-specific tissue malfunctions or cancer vulnerabilities.

KW - Breast cancer

KW - Estrogens

KW - Immune system

KW - Ligand mixtures

KW - Membrane estrogen receptors

KW - Neurons

KW - Nongenomic

KW - Nonmonotonic

KW - Pituitary

KW - Xenoestrogens

UR - http://www.scopus.com/inward/record.url?scp=84929292000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929292000&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-1764-4_8

DO - 10.1007/978-1-4614-1764-4_8

M3 - Chapter

SN - 9781461417644

SN - 1461417635

SN - 9781461417637

SP - 129

EP - 142

BT - Advances in Rapid Sex-Steroid Action: New Challenges and New Chances in Breast and Prostate Cancers

PB - Springer New York

ER -